Tamsulosin for benign prostatic hyperplasia

被引:0
|
作者
不详
机构
来源
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 1997年 / 39卷 / 1011期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:96 / 96
页数:1
相关论文
共 50 条
  • [1] Dutasteride/Tamsulosin In Benign Prostatic Hyperplasia
    Keating, Gillian M.
    [J]. DRUGS & AGING, 2012, 29 (05) : 405 - 419
  • [2] Tamsulosin in urology: beyond benign prostatic hyperplasia
    Prabhu, G. G. Laxman
    Prajapati, Hiren
    Chaturvedi, Alok
    Dave, Nilanj
    Jain, Amit B.
    [J]. DRUGS & THERAPY PERSPECTIVES, 2019, 35 (04) : 181 - 184
  • [3] Dutasteride/Tamsulosin (Jalyn) for Benign Prostatic Hyperplasia
    Wilson, Stephen A.
    Broders, Jennie
    [J]. AMERICAN FAMILY PHYSICIAN, 2012, 85 (12) : 1194 - 1195
  • [4] Tamsulosin in urology: beyond benign prostatic hyperplasia
    G. G. Laxman Prabhu
    Hiren Prajapati
    Alok Chaturvedi
    Nilanj Dave
    Amit B. Jain
    [J]. Drugs & Therapy Perspectives, 2019, 35 : 181 - 184
  • [5] Tamsulosin and chlormadinone for the treatment of benign prostatic hyperplasia
    Okada, H
    Kawaida, N
    Ogawa, T
    Arakawa, S
    Matsumoto, O
    Kamidono, S
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1996, 30 (05): : 379 - 385
  • [6] Dutasteride (Avodart) with Tamsulosin (Flomax) for Benign Prostatic Hyperplasia
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2008, 50 (1296): : 79 - 80
  • [7] EFFICACY AND SAFETY OF TAMSULOSIN IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    KAWABE, K
    [J]. BRITISH JOURNAL OF UROLOGY, 1995, 76 : 63 - 67
  • [8] Management of benign prostatic hyperplasia - Defining the role of tamsulosin
    Croom, KF
    Wagstaff, AJ
    [J]. DISEASE MANAGEMENT & HEALTH OUTCOMES, 2004, 12 (05) : 337 - 350
  • [9] Abnormal ejaculation associated with tamsulosin in benign prostatic hyperplasia patients
    Naruganahalli, Krishna S.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (12) : 1635 - 1638
  • [10] Development of microemulsion of tamsulosin and dutasteride for benign prostatic hyperplasia therapy
    Ciriaco, Shayara Lopes
    Santos Carvalho, Ivana Pereira
    Terceiro Neto, Jose Alves
    Lima Neto, Jose de Sousa
    Bento de Oliveira, Daniel Henrique
    Gomes Pereira Cunha, Ana Paula
    Duarte Cavalcante, Ykro Talvanis
    Casimiro da Silva, Dayane Tomaz
    da Silva, Jose Alexsandro
    Bezerra Barradas Mineiro, Ana Lys
    de Lima Chagas Moreno Fernandes, Maria Zenaide
    Menezes Carvalho, Andre Luis
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2020, 185